1,736,204 research outputs found
Avian Influenza-SSD2 Laboratory Data Model
No full text<p>This document describes the data model for reporting data on <strong>analytical test results</strong> and related metadata to EFSA. The data model described here will be used for the first time in EFSA's Avian Influenza data collection for samples collected in 2023. </p><p>For all the relevant data elements, definitions and information on data types and reporting constraints are provided. The elements controlled by EFSA catalogues terminology are indicated and all the admissible values are presented for each data element. Additionally, the business rules associated with the quality checks are listed, in order to facilitate the data preparation appropriately. Finally, some general definitions are provided to help you inspect the data model more efficiently.</p><p>You can browse through the different tabs to explore the data model and the business rules, as well as all the related data element values from the different catalogues. For an easier navigation between the data model and the catalogue tabs, you can click on the name of the catalogue you want to review, located in the central tab of the data model, and you will be transferred directly to the respective tab. You can also click on the 'Back to data model' button to go back and forth on several tabs</p><p>EU; xlsx; [email protected] </p>
The EFSA Excel mapping tool to be used to report 2023 zoonoses data and sample-based results of Echinococcus multilocularis under the Commission Delegated Regulation (EU) 2018/772
No full text<p>The main objective of the mapping tools is to provide a simple and useable platform for Member states and other reporting countries to map their country-specific standard terminology to that used by EFSA and to enable the production of an XML file for the submission of sample or aggregated-based zoonoses monitoring data via the Data Collection Framework (DCF).</p>
<p>The catalogues and the specific hierarchy of each data model (AMR, ESBL, PRV, FBO, AP, DS and SSD2 for <em>Echinococcus multilocularis</em>) are already inserted into each of the specific mapping tool. Specific Excel mapping tools corresponding to each of the five data models are available.</p>
<p>Dynamic or manual version of the tool can be chosen for the first six data models.</p>
<p>The Emulti_SSD2_tool can be used to report sample-based results of <em>Echinococcus multilocularis</em> under the Commission Delegated Regulation (EU) 2018/772.</p><p><span>EU; xlsx; [email protected];</span></p>
Safety of UV-treated powder of whole yellow mealworm (Tenebrio molitor larva) as a novel food pursuant to Regulation (EU) 2015/2283.
No full text© 2023 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority.Peer reviewe
Update of the risk assessment of hexabromocyclododecanes (HBCDDs) in food: Occurrence data in food submitted to EFSA and dietary exposure assessment for humans
No full textAnnex A – Protocol for the risk assessments for human health related to the presence of brominated flame retardants (BFRs) in food The Annex is provided as a separate pdf file containing the risk assessment protocol selected by the CONTAM Panel to update the previous risk assessments of brominated flame retardants (BFRs) in food. Annex B: Occurrence data on HBCDDs in food submitted to EFSA and dietary surveys per country and age group available in the EFSA Comprehensive Database, considered in the exposure assessment Table B.1 Number of analytical results excluded from the initial dataset during data cleaning, and justification for exclusion Table B.2 Occurrence values of HBCDDs calculated total (µg/kg) by food category in the final dataset Table B.3 Food categories of FoodEx and mean LB and UB values as used for the exposure assessment Table B.4 Dietary surveys and the number of subjects by country and population class, available for the chronic exposure assessment, in the EFSA Comprehensive European Food Consumption Database Table B.5 Summary statistics on data reported for HBCDDs total, analysed with GC-MS, not considered for the exposure Figure B.1 Frequency distribution of the occurrence values for the food categories of interest at the LB without zeros presented on a log 10 scale Figure B.2 Frequency distribution of the occurrence values for the food categories of interest at the UB presented on a log 10 scale HBCDDs_Raw_Occurrence_Data.CSV contains the raw occurrence dataset on Hexabromocyclododecanes (HBCDDs) contaminant as extracted from EFSA DWH in December 2019 on 2530 food samples presented in the opinion as described in its section 3.2.1. Occurrence data submitted to EFSA. The data is provided in .csv format. This dataset is compliant with EFSA SSD model and contains two additional columns documenting issues identified in the cleaning process (column: issue) and the action taken (column: outcome) to address the issue (e.g. delete record or update values in specific fields)
Safety of chia seeds (Salvia hispanica L.) powders, as novel foods, pursuant to Regulation (EU) 2015/2283
No full textFollowing a request from the European Commission, the EFSA Panel on Nutrition, Novel foods and Food Allergens (NDA) was asked to deliver an opinion on chia seeds (Salvia hispanica L.) powders as novel foods (NFs) pursuant to Regulation (EU) 2015/2283. The NFs are partially defatted chia seed powders, obtained by extrusion of whole seeds of S. hispanica L. with the main differences between two powders in particle sizes and the content of some macronutrients. The information provided on the production processes, composition, batch-to-batch variability, stability and specifications of the NFs is sufficient and does not raise safety concerns. The applicant proposed to market the NFs as food supplements and as ingredients in a variety of foods. The target population for the NFs is the general population. Noting that no hazard raising safety concerns (except for allergenicity) could be identified from the information available on the source (i.e. chia seeds), the production processes, composition, specifications and proposed uses of the NFs, irrespectively of the maximum use levels at the proposed uses, the Panel considers that intake estimates and additional toxicological data for the NFs are not needed for this assessment. The Panel concludes that the NFs, partially defatted powders of whole chia seeds, are safe under the assessed conditions of use. (C) 2019 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.Peer reviewe
Microbial species as notified to EFSA
No full textThis is the list of “Microbiological agents as notified to EFSA” from 2007, in the context of technical dossiers to EFSA Units, for intentional use in feed and/or food or as sources of food and feed additives, enzymes and plant protection products (PPPs) for safety assessment
Estimation / calculation of emissions of Plant Protection Products from protected crops (greenhouses and cultivations grown under cover) to support the development of risk assessment methodology under Regulation (EC) N° 1107/2009 and Council Directive 91/414/EEC
No full textRisk assessment on Glycoalkaloids in feed and food: Occurrence data in food and feed submitted to EFSA and dietary exposure assessment for humans
No full textUPDATE to version 2 of this upload: Also the raw (no data cleaning applied to it) occurrence dataset as extracted from EFSA DWH is provided in csv format. This dataset is compliant with EFSA SSD model and contains two additional columns documenting issues identified in the cleaning process (column: issue) and the action taken (column: action) to address the issue (e.g. delete record or update values in specific fields). Description - Version 1 Annex: Tables on GAs on occurrence data in food and feed, and dietary exposure assessment for humans Table A.1. Dietary surveys used for the estimation of acute dietary exposure to GA Table A.2. Number of results and samples per food category submitted to EFSA through the continuous call for data Table A.3. Analytical results excluded from the final dataset used to estimate dietary exposure and the criteria applied for exclusion Table A.4. Occurrence of alpha-chaconine and alpha-solanine (UB mg/kg) in the samples included in the final dataset (left censored results highlighted in yellow) Table A.5. European Starch Association data on feed and potatoes for starch Table A.6. Details acute assessment across surveys (consumption days only) Table A.7. Comparison of exposure summary results obtained using the uniform vs the normal distribution for reduction factor
Statement complementing the EFSA GMO Panel scientific opinion on maize MON 89034 x 1507 x NK603 (application EFSA-GMO-NL-2009-65), to cover all sub-combinations independently of their origin
No full textFollowing a request from the European Commission, the Panel on Genetically Modified Organisms of the European Food Safety Authority (EFSA GMO Panel) was asked to complement its scientific opinion on insect resistant and herbicide tolerant genetically modified (GM) maize MON 89034 x
1507 x NK603 (application EFSA-GMO-NL-2009-65) issued in 2010, to cover all sub-combinations independently of their origin. The EFSA GMO Panel scientific opinion covered the safety assessment of maize MON 89034 x 1507 x NK603 and all sub-combinations of the individual events as present in
its segregating progeny, for food and feed uses, import and processing under Regulation (EC) No 1829/2003. Each single event present in maize MON 89034 x 1507 x NK603 and two of the three possible sub-combinations, namely maize 1507 x NK603 (EFSA-GMO-UK-2004-05) and maize MON 89034 x NK603 (EFSA-GMO-NL-2007-38), were previously assessed by the EFSA GMO Panel. In view of the European Commission’s request and, having considered all relevant available information on maize MON 89034 x 1507 x NK603 and on the single maize events, the EFSA GMO Panel considers it unlikely that the sub-combinations have an adverse effect on human and animal health and the environment in the context of their intended uses, which cover food and feed uses, import and processing. This conclusion was further supported by the previous assessments of maize 1507 x NK603 and maize MON 89034 x NK603. The EFSA GMO Panel concludes that the present statement can complement the scientific opinion on maize MON 89034 x 1507 x NK603 to cover all sub-combinations independently of their origin
Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs : Executive summary
No full textAdopted 11 December 2014 Panel members: Claudia Bolognesi, Laurence Castle, Jean-Pierre Cravedi, Karl-Heinz Engel, Paul Fowler, Roland Franz, Konrad Grob, Rainer Gürtler, Trine Husøy, Wim Mennes, Maria Rosaria Milana, André Penninks, Franz Roland, Vittorio Silano, Andrew Smith, Maria de Fátima Tavares Poças, Christina Tlustos, Fidel Toldrá, Detlef Wölfle and Holger Zorn. Acknowledgement: The Panel wishes to thank the members of the Working Groups on BPA Exposure and Toxicology: Claire Beausoleil, Diane Benford, Emma Bradley, Anne Lise Brantsaeter, Gemma Calamandrei, Daniel Doerge, Paul Fowler, Peter Greaves (until July 2012), Ursula Gundert-Remy, Andrew David Hart, Edel Holene, Trine Husøy, Catherine Leclercq (until July 2013), Inger Therese Laugsand Lillegaard, Wim Mennes, Ralph Pirow, Maria de Fátima Tavares Poças, Iona Pratt (deceased in February 2014), Josef Rudolf Schlatter, Catherine Simoneau, Wout Slob, Jacqueline Van Engelen, Henk Van Loveren, Natalie Von Götz, Detlef Wölfle and Rudolf Antonius Woutersen for the preparatory work on this scientific opinion and the hearing experts: Jan Alexander, Pasquale Mosesso and Alfonso Siani, and EFSA staff: Davide Arcella, Anna F. Castoldi, Cristina Croera and Anne Theobald for the support provided to this scientific opinion. Suggested citation: EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2015. Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs: Executive summary. EFSA Journal 2015;13(1):3978, 22 pp. doi:10.2903/j.efsa.2015.397
- …
